Who Paid My Doc
Aortix System
Device Cardiac Arrhythmias and Heart Failure
General payments
$221,026
Research payments
$4,382,513
Through program year 2025, $221,026 in general payments and $4,382,513 in research payments were reported against Aortix System (Cardiac Arrhythmias and Heart Failure).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $64,844 | 137 |
| 2025 | Research | $1,773,308 | 48 |
| 2024 | General | $53,429 | 199 |
| 2024 | Research | $1,433,900 | 40 |
| 2023 | General | $36,368 | 28 |
| 2023 | Research | $288,580 | 18 |
| 2022 | General | $33,094 | 55 |
| 2022 | Research | $758,598 | 13 |
| 2021 | General | $33,291 | 26 |
| 2021 | Research | $128,126 | 5 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 17 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 20 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
445 general · 124 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.